Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's Disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's Disease here.

September 13, 2020

Downregulation of G3BP2 reduces atherosclerotic lesions in ApoE-/- mice

Atherosclerosis
Tianhan LiGuixue Wang
September 14, 2020

The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years

The Journal of Prevention of Alzheimer's Disease
S WalterP S Aisen
September 15, 2020

Neopterin derivatives - a novel therapeutic target rather than biomarker for atherosclerosis and related diseases

VASA. Zeitschrift für Gefässkrankheiten
Takuya Watanabe
September 11, 2020

Genetics of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease: a 1-Year Follow-Up Study

Psychiatry and Clinical Neurosciences
Mei-Feng HuangJong-Ling Fuh
September 16, 2020
Open Access

Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice

International Journal of Molecular Sciences
Alejandro R RodaSandra Villegas
September 15, 2020
Open Access

Transcriptome Analyses in BV2 Microglial Cells Following Treatment With Amino-Terminal Fragments of Apolipoprotein E

Frontiers in Aging Neuroscience
Tanner B PollockTroy T Rohn
September 10, 2020
Review
Open Access

The Other Side of Alzheimer's Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers

Journal of Personalized Medicine
Chiara ArgentatiSabata Martino
September 15, 2020

CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Carmen Gutiérrez-MuñozLuis M Blanco-Colio
September 15, 2020

Cognitive, Genetic, Brain Volume, and Diffusion Tensor Imaging Markers as Early Indicators of Dementia

Journal of Alzheimer's Disease : JAD
Theresa MüllerErika J Laukka
September 15, 2020
Open Access

The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer's disease

Acta Neuropathologica
Baayla D C BoonJeroen J M Hoozemans
September 15, 2020

Microbleeds and Medial Temporal Atrophy Determine Cognitive Trajectories in Normal Aging: A Longitudinal PET-MRI Study

Journal of Alzheimer's Disease : JAD
Marie-Louise MontandonPanteleimon Giannakopoulos
September 17, 2020

Effect of estradiol on enzymes of vascular extracellular nucleotide metabolism

Hormones : International Journal of Endocrinology and Metabolism
Areta HebanowskaAlicja Braczko
September 15, 2020

Dynamic monitoring of active calcification in atherosclerosis by 18 F-NaF PET imaging

The International Journal of Cardiovascular Imaging
Yan HuHongcheng Shi
September 15, 2020

Positive association of a Sirt1 variant and parameters of oxidative stress on Alzheimer's disease

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Daniela CamporezFlavia de Paula
September 12, 2020
Open Access

Association of common genetic variants with brain microbleeds: A Genome-wide Association Study

Neurology
Maria J KnolAlzheimer’s Disease Neuroimaging Initiative
September 11, 2020

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer's pathology

Annals of Clinical and Translational Neurology
Hao HuJin-Tai Yu
September 14, 2020

The Interrelationship between Insulin-Like Growth Factor 1, Apolipoprotein E ε4, Lifestyle Factors, and the Aging Body and Brain

The Journal of Prevention of Alzheimer's Disease
S A GalleM L Drent

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-apoe/a7aa2901-c4ab-41a5-bdac-8636d52b2090